Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
Wockhardt's yet another novel antibiotic Miqnaf receives favourable recommendation from Subject Expert Committee of CDSCO
We now rank 3rd in pharmaceutical production by volume and 14th by value
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
The BPaLM regimen, which consists four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Subscribe To Our Newsletter & Stay Updated
